Stay updated on aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.

Latest updates to the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page
- Check4 days agoChange DetectedThe study page shows a revised metadata version from v3.5.4 to v3.5.5, indicating a minor maintenance update; no changes to the study details themselves are indicated.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now shows revision v3.5.4 instead of v3.5.3, representing an internal maintenance or update to the site's revision tracking.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision: v3.5.3 was added to the study record, replacing the previous Revision: v3.5.2. This signals a minor administrative update to the study metadata rather than any changes to the trial content or conduct.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated: v3.5.0 was removed and v3.5.2 was added.SummaryDifference0.1%

- Check76 days agoChange DetectedFooter revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.